Erik Riley

EVP and CFO, Ajinomoto Bio-Pharma Services

Professional Overview
Erik Riley is an accomplished finance executive with extensive experience in the biopharmaceutical industry. As the Executive Vice President and Chief Financial Officer of Ajinomoto Bio-Pharma Services, he oversees the company's financial strategy, reporting, and operations, playing a pivotal role in driving the organization's growth and profitability.

Experience Summary

Current Role
In his current role as EVP and CFO, Erik is responsible for managing Ajinomoto Bio-Pharma Services' financial affairs, including financial planning, analysis, and reporting. He works closely with the executive team to align financial strategies with the company's overall business objectives, ensuring efficient resource allocation and sound decision-making. Under Erik's financial leadership, Ajinomoto Bio-Pharma Services has streamlined its operations, improved cost efficiencies, and achieved significant revenue growth.

Career Progression
Prior to his current role, Erik held various leadership positions within the biopharmaceutical industry. He served as the Senior Vice President and CFO at Ajinomoto Bio-Pharma Services, where he played a critical role in the integration of two business units, driving synergies and improving financial performance. Before that, he was the Vice President of Corporate Strategy, responsible for developing and implementing strategic initiatives to enhance the company's competitive position.

Erik's earlier career includes roles at HOMMA, Inc., where he oversaw finance and administration, and Ingram Micro, where he served as the Director of Financial Planning and Analysis. He also has entrepreneurial experience, having run a small/new business venture.

Academic Background
Erik holds a Bachelor's degree in Business Administration from a reputable university, with a focus on finance and accounting.

Areas of Expertise

• Financial planning and analysis

• Strategic financial management

• Cost optimization and operational efficiency

• M&A integration and synergy realization

• Business strategy and transformation

• Leadership and team development

Professional Impact
During his tenure at Ajinomoto Bio-Pharma Services, Erik has played a pivotal role in driving the company's financial performance and strategic growth. He has led the implementation of advanced financial reporting systems, improved working capital management, and streamlined the organization's cost structure, resulting in significant improvements in profitability and cash flow.

Erik's strategic vision and financial acumen have been instrumental in facilitating the successful integration of two business units, unlocking synergies and enhancing the company's competitive positioning in the biopharmaceutical contract manufacturing market.

Conclusion
With his extensive experience in the biopharmaceutical industry and a proven track record of financial leadership, Erik Riley is well-positioned to continue driving Ajinomoto Bio-Pharma Services' growth and financial success. His strategic financial management, cost optimization expertise, and strong leadership skills make him a valuable asset to the organization.